Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSofos Investments, Inc.
Latest Disclosed Ownership4 shares
Latest Disclosed Value $ 1,786
Sofos Investments, Inc. ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 8, 2026 - Sofos Investments, Inc. filed a 13F-HR form disclosing ownership of 4 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,786 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 6, 2024 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $1,713 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS I COMMON STOCK 92532F100 4 4 2 0.0003
2024-08-06 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -7 -100.00 0 -100.00
2024-06-26 2024-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 7 -5 -41.67 3 -60.00 0.0008
2024-05-13 2024-03-31 13F Vertex Pharmaceuticals, Inc. Ordinary Shares COM 92532F100 32 20 13 0.0034
2024-06-26 2023-12-31 13F/A-1 Vertex Pharmaceuticals, Inc. Ordinary Shares Domestic Equities 92532F100 12 1 9.09 5 25.00 0.0014
2024-02-15 2023-12-31 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 11 0 4 0.0000
2023-11-16 2023-09-30 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 11 -341 -96.88 4 0.00 0.0000
2023-08-09 2023-06-30 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 352 37 11.75 5 0.00 0.0124
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 315 26 9.00 5 0.00 0.1420
2023-02-15 2022-12-31 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 289 -7,831 -96.44 4 0.00 0.0210
2022-11-03 2022-09-30 13F VERTEX PHARMACEUTICALS Domestic Equities 92532F100 8,120 -340 -4.02 4 0.00 0.1505
2022-08-05 2022-06-30 13F VERTEX PHARMACEUTICALS Stock 92532F100 8,460 630 8.05 5 0.00 0.1429
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS Stock 92532F100 7,830 4,970 173.78 5 300.00 0.1354
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS Stock 92532F100 2,860 2,853 40,757.14 2 0.0366
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS Stock 92532F100 7 0 0.00 0 0.0852
2021-08-11 2021-06-30 13F VERTEX PHARMACEUTICALS Stock 92532F100 7 -4 -36.36 0 -100.00 0.0724
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS Stock 92532F100 11 -33 -75.00 2 -80.00 0.0484
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COMSTOCK 92532F100 44 44 10 0.0092
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COMSTOCK 92532F100 0 -297 -100.00 0 -100.00
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS COMSTOCK 92532F100 297 -206 -40.95 71 -68.04 0.2184
2020-02-28 2019-12-31 13F VERTEX PHARMACEUTICALS STOCK 92532F100 503 -251 -33.29 219 71.09 0.1509
2019-10-15 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 754 -167 -18.13 128 -24.26 0.1102
2019-07-26 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 921 -197 -17.62 169 -18.75 0.1387
2019-04-19 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,118 -216 -16.19 208 -8.37 0.1682
2018-10-31 2018-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,334 214 19.11 227 15.82 0.2376
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,120 -96 -7.89 196 7.69 0.1838
2018-05-23 2018-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,216 1,216 182 0.1863
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.